Related references
Note: Only part of the references are listed.Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
Rinat Yerushalmi et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways
Tania Benatar et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation
C. E. Tognon et al.
ONCOGENE (2012)
ZEB2 Mediates Multiple Pathways Regulating Cell Proliferation, Migration, Invasion, and Apoptosis in Glioma
Songtao Qi et al.
PLOS ONE (2012)
Mammary tumors that become independent of the type I insulin-like growth factor receptor express elevated levels of platelet-derived growth factor receptors
Craig I. Campbell et al.
BMC CANCER (2011)
Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors
Y. Amemiya et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Insulin-like growth factor-1 receptor gene expression is associated with survival in breast cancer: a comprehensive analysis of gene copy number, mRNA and protein expression
Peifen Fu et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
ETV6-NTRK3-Mediated Breast Epithelial Cell Transformation Is Blocked by Targeting the IGF1R Signaling Pathway
Cristina E. Tognon et al.
CANCER RESEARCH (2011)
Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer
Elizabeth Buck et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells
Yongxian Zhuang et al.
MOLECULAR CANCER RESEARCH (2011)
Impact of oncogenic K-RAS on YB-1 phosphorylation induced by ionizing radiation
Mahmoud Toulany et al.
BREAST CANCER RESEARCH (2011)
Defining the pathway to insulin-like growth factor system targeting in cancer
Steven A. Rosenzweig et al.
BIOCHEMICAL PHARMACOLOGY (2010)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
Synthetic Lethality Screens Reveal RPS6 and MST1R as Modifiers of Insulin-like Growth Factor-1 Receptor Inhibitor Activity in Childhood Sarcomas
Jenny C. Potratz et al.
CANCER RESEARCH (2010)
Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer
Elizabeth Buck et al.
MOLECULAR CANCER THERAPEUTICS (2010)
A Kinase-Independent Role for Unoccupied Insulin and IGF-1 Receptors in the Control of Apoptosis
Jeremie Boucher et al.
SCIENCE SIGNALING (2010)
Calpain activation through galectin-3 inhibition sensitizes prostate cancer cells to cisplatin treatment
Y. Wang et al.
CELL DEATH & DISEASE (2010)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Efficacy of IGFBP7 for treatment of metastatic melanoma and other cancers in mouse models and human cell lines
Narendra Wajapeyee et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Jennifer H. Law et al.
CANCER RESEARCH (2008)
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7
Narendra Wajapeyee et al.
CELL (2008)
Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways
Emmanuel Agbottah et al.
AIDS Research and Therapy (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion
Jing Deng et al.
CANCER RESEARCH (2007)
Strong suppression of tumor growth by insulin-like growth factor-binding protein-related protein 1/tumor-derived cell adhesion factor/mac25
Yuichiro Sato et al.
CANCER SCIENCE (2007)
The role of the IGF system in cancer growth and metastasis: Overview and recent insights
Amir Abbas Samani et al.
ENDOCRINE REVIEWS (2007)
Phosphatidylinositol-3-OH kinase or RAS pathway mutations in human breast cancer cell lines
Antoinette Hollestelle et al.
MOLECULAR CANCER RESEARCH (2007)
Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin
Hua Zhang et al.
CANCER RESEARCH (2007)
Repression of cap-dependent translation attenuates the transformed phenotype in non-small cell lung cancer both in vitro and in vivo
BA Jacobson et al.
CANCER RESEARCH (2006)
Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25)
S Ahmed et al.
FEBS JOURNAL (2006)
Akt-mediated YB-1 phosphorylation activates translation of silent mRNA species
V Evdokimova et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells
GM Yanochko et al.
BREAST CANCER RESEARCH (2006)
Discovery of a 1H-benzoimidazol-2-yl)-1H-pyridin-2-one (BMS-536924) inhibitor of insulin-like growth factor I receptor kinase with in vivo antitumor activity
M Wittman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer
AM Burger et al.
EUROPEAN JOURNAL OF CANCER (2005)
The cyclolignan PPP induces activation loop-specific inhibition of tyrosine phosphorylation of the insulin-like growth factor-1 receptor. Link to the phosphatidyl inositol-3 kinase/Akt apoptotic pathway
D Vasilcanu et al.
ONCOGENE (2004)
Cellular actions of the insulin-like growth factor binding proteins
SM Firth et al.
ENDOCRINE REVIEWS (2002)
Translational control of cell fate: Availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency
SN Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Caspase cleavage of initiation factor 4E-binding protein 1 yields a dominant inhibitor of cap-dependent translation and reveals a novel regulatory motif
AR Tee et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells
SJ Santner et al.
BREAST CANCER RESEARCH AND TREATMENT (2001)
Insulin-like growth factor (IGF) binding protein-3 inhibits type 1 IGF receptor activation independently of its IGF binding affinity
JM Ricort et al.
ENDOCRINOLOGY (2001)
Structural requirements of heparan sulfate for the binding to the tumor-derived adhesion factor/angiomodulin that induces cord-like structures to ECV-304 human carcinoma cells
J Kishibe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
